• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用磁共振波谱评估非酒精性脂肪性肝炎进展过程中的肝内脂肪酸。

Assessment of hepatic fatty acids during non-alcoholic steatohepatitis progression using magnetic resonance spectroscopy.

机构信息

Biomedical Imaging Center, Pontificia Universidad Católica de Chile, Santiago, Chile; ANID, Millennium Science Initiative Program, Millennium Nucleus for Cardiovascular Magnetic Resonance, Santiago, Chile; Instituto de Ciencias de la Ingeniería, Universidad de O'Higgins, Rancagua, Chile.

Faculty of Chemistry and Pharmacy, Pontificia Universidad Católica de Chile, Santiago, Chile; Research Center for Nanotechnology and Advanced Materials CIEN-UC, Pontificia Universidad Católica de Chile, Santiago, Chile; Institute for Biological and Medical Engineering, Schools of Engineering, Medicine and Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.

出版信息

Ann Hepatol. 2021 Nov-Dec;25:100358. doi: 10.1016/j.aohep.2021.100358. Epub 2021 May 4.

DOI:10.1016/j.aohep.2021.100358
PMID:
33962045
Abstract

INTRODUCTION AND OBJECTIVES

Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of liver abnormalities including steatosis, steatohepatitis, fibrosis, and cirrhosis. Liver biopsy remains the gold standard method to determine the disease stage in NAFLD but is an invasive and risky procedure. Studies have previously reported that changes in intrahepatic fatty acids (FA) composition are related to the progression of NAFLD, mainly in its early stages. The aim of this study was to characterize the liver FA composition in mice fed a Choline-deficient L-amino-defined (CDAA) diet at different stages of NAFLD using magnetic resonance spectroscopy (MRS).

METHODS

We used in-vivo MRS to perform a longitudinal characterization of hepatic FA changes in NAFLD mice for 10 weeks. We validated our findings with ex-vivo MRS, gas chromatography-mass spectrometry and histology.

RESULTS

In-vivo and ex-vivo results showed that livers from CDAA-fed mice exhibit a significant increase in liver FA content as well as a change in FA composition compared with control mice. After 4 weeks of CDAA diet, a decrease in polyunsaturated and an increase in monounsaturated FA were observed. These changes were associated with the appearance of early stages of steatohepatitis, confirmed by histology (NAFLD Activity Score (NAS) = 4.5). After 10 weeks of CDAA-diet, the liver FA composition remained stable while the NAS increased further to 6 showing a combination of early and late stages of steatohepatitis.

CONCLUSION

Our results suggest that monitoring lipid composition in addition to total water/fat with MRS may yield additional insights that can be translated for non-invasive stratification of high-risk NAFLD patients.

摘要

简介和目的

非酒精性脂肪性肝病(NAFLD)包括一系列肝脏异常,包括脂肪变性、脂肪性肝炎、纤维化和肝硬化。肝活检仍然是确定 NAFLD 疾病阶段的金标准方法,但它是一种侵入性和有风险的程序。先前的研究报告称,肝内脂肪酸(FA)组成的变化与 NAFLD 的进展有关,主要是在其早期阶段。本研究的目的是使用磁共振波谱(MRS)在不同阶段的 NAFLD 小鼠中描述胆碱缺乏 L-氨基酸定义(CDAA)饮食喂养的小鼠的肝 FA 组成。

方法

我们使用体内 MRS 对 NAFLD 小鼠进行 10 周的肝 FA 变化进行纵向特征描述。我们使用体外 MRS、气相色谱-质谱和组织学验证了我们的发现。

结果

体内和体外结果表明,与对照小鼠相比,CDAA 喂养的小鼠的肝脏 FA 含量显著增加,并且 FA 组成发生变化。在 CDAA 饮食 4 周后,观察到多不饱和 FA 减少和单不饱和 FA 增加。这些变化与组织学上观察到的早期脂肪性肝炎相一致(NAFLD 活动评分(NAS)= 4.5)。在 CDAA 饮食 10 周后,肝脏 FA 组成保持稳定,而 NAS 进一步增加至 6,显示出早期和晚期脂肪性肝炎的结合。

结论

我们的结果表明,除了使用 MRS 监测总水/脂肪外,监测脂质组成可能会提供额外的见解,这些见解可以转化为非侵入性高危 NAFLD 患者的分层。

相似文献

1
Assessment of hepatic fatty acids during non-alcoholic steatohepatitis progression using magnetic resonance spectroscopy.使用磁共振波谱评估非酒精性脂肪性肝炎进展过程中的肝内脂肪酸。
Ann Hepatol. 2021 Nov-Dec;25:100358. doi: 10.1016/j.aohep.2021.100358. Epub 2021 May 4.
2
Ultra-high-field magnetic resonance spectroscopy in non-alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non-alcoholic steatohepatitis and advanced fibrosis.超高场磁共振波谱在非酒精性脂肪性肝病中的应用:非酒精性脂肪性肝炎和肝纤维化能量代谢的新机制和诊断见解。
Liver Int. 2017 Oct;37(10):1544-1553. doi: 10.1111/liv.13451. Epub 2017 May 20.
3
Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.比较小鼠脂肪性肝炎模型可识别出一种具有显著纤维化、胆管反应、快速进展为肝硬化和癌症的饮食干预措施。
Am J Physiol Gastrointest Liver Physiol. 2020 Jan 1;318(1):G174-G188. doi: 10.1152/ajpgi.00041.2019. Epub 2019 Oct 21.
4
Characterization of hepatic fatty acids using magnetic resonance spectroscopy for the assessment of treatment response to metformin in an eNOS mouse model of metabolic nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.采用磁共振波谱技术对肝脏脂肪酸进行特征分析,以评估内皮型一氧化氮合酶(eNOS)小鼠代谢性非酒精性脂肪性肝病/非酒精性脂肪性肝炎模型中二甲双胍治疗反应。
NMR Biomed. 2023 Aug;36(8):e4932. doi: 10.1002/nbm.4932. Epub 2023 Apr 11.
5
Attenuation of the Hepatoprotective Effects of Ileal Apical Sodium Dependent Bile Acid Transporter (ASBT) Inhibition in Choline-Deficient L-Amino Acid-Defined (CDAA) Diet-Fed Mice.在胆碱缺乏的L-氨基酸限定(CDAA)饮食喂养的小鼠中,回肠顶端钠依赖性胆汁酸转运体(ASBT)抑制的肝脏保护作用减弱。
Front Med (Lausanne). 2020 Feb 25;7:60. doi: 10.3389/fmed.2020.00060. eCollection 2020.
6
Validation of water-fat MRI and proton MRS in assessment of hepatic fat and the heterogeneous distribution of hepatic fat and iron in subjects with non-alcoholic fatty liver disease.水脂 MRI 和质子 MRS 对非酒精性脂肪性肝病患者肝脂肪和肝脂肪及铁异质性分布评估的验证。
Eur J Radiol. 2018 Oct;107:7-13. doi: 10.1016/j.ejrad.2018.08.008. Epub 2018 Aug 11.
7
Myeloid-specific blockade of Notch signaling ameliorates nonalcoholic fatty liver disease in mice.髓系细胞特异性阻断 Notch 信号通路可改善小鼠非酒精性脂肪性肝病。
Int J Biol Sci. 2023 Mar 27;19(6):1941-1954. doi: 10.7150/ijbs.80122. eCollection 2023.
8
Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.病态肥胖中的肝脏脂肪沉积和线粒体功能障碍:一种将代谢组学与肝脏成像和组织学相结合的方法。
World J Gastroenterol. 2015 Jun 28;21(24):7529-44. doi: 10.3748/wjg.v21.i24.7529.
9
NLRP3 inflammasome activation is required for fibrosis development in NAFLD.NLRP3炎性小体激活是NAFLD中纤维化发展所必需的。
J Mol Med (Berl). 2014 Oct;92(10):1069-82. doi: 10.1007/s00109-014-1170-1. Epub 2014 May 28.
10
Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time.肝脏丙氨酸可将人类和小鼠的非酒精性脂肪性肝炎与单纯性脂肪变性区分开来:质子磁共振波谱研究与长回波时间。
J Magn Reson Imaging. 2017 Nov;46(5):1298-1310. doi: 10.1002/jmri.25673. Epub 2017 Feb 22.

引用本文的文献

1
Sex differences in the relationship between body composition and MASLD progression in a murine model of metabolic syndrome.代谢综合征小鼠模型中身体组成与代谢相关脂肪性肝病进展关系的性别差异
iScience. 2025 Jan 20;28(2):111863. doi: 10.1016/j.isci.2025.111863. eCollection 2025 Feb 21.
2
Liver magnetic resonance spectroscopy as an alternative for evaluating Niemann-Pick C disease progression.肝脏磁共振波谱分析作为评估尼曼-匹克C型病进展的一种替代方法。
RSC Adv. 2025 Feb 6;15(6):4079-4085. doi: 10.1039/d4ra06781a.
3
Characterization of hepatic fatty acids using magnetic resonance spectroscopy for the assessment of treatment response to metformin in an eNOS mouse model of metabolic nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
采用磁共振波谱技术对肝脏脂肪酸进行特征分析,以评估内皮型一氧化氮合酶(eNOS)小鼠代谢性非酒精性脂肪性肝病/非酒精性脂肪性肝炎模型中二甲双胍治疗反应。
NMR Biomed. 2023 Aug;36(8):e4932. doi: 10.1002/nbm.4932. Epub 2023 Apr 11.
4
Is Fat Deposition of Renal Sinus a Concomitant Finding to Fatty Liver Disease? The First Study Regarding the Relationship Between Kidney and Liver Fat Content with Non-Contrast Computed Tomography.肾窦脂肪沉积是脂肪肝疾病的伴随表现吗?关于肾脏与肝脏脂肪含量关系的非增强计算机断层扫描的首次研究。
Spartan Med Res J. 2022 Feb 24;7(1):32411. doi: 10.51894/001c.32411. eCollection 2022.